VOXZOGO 1.2 mg, powder and solvent for solution for injection 10 bottles of 0.6 ml + 10 needles
Active ingredients: Vosoritide
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injection10 bottles of 0.6 ml + 10 needlessous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VOXZOGO 1,2 mg, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 10 flacons en verre de 1,2 mg + 10 seringues préremplies en verre de 0,6 ml + 10 aiguilles + 10 seringues d'administration
- Marketing authorisation holder
- BIOMARIN INTERNATIONAL LIMITED (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Apr 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Initial prescription by a specialist
- Renewal by a specialist only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68092884CIP73023670CIP133400930236703Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VOSORITIDEpoudre | 1,2 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.